Your browser doesn't support javascript.
loading
Small intestinal submucosa-derived extracellular matrix as a heterotopic scaffold for cardiovascular applications.
Palmosi, Tiziana; Tolomeo, Anna Maria; Cirillo, Carmine; Sandrin, Debora; Sciro, Manuela; Negrisolo, Susanna; Todesco, Martina; Caicci, Federico; Santoro, Michele; Dal Lago, Eleonora; Marchesan, Massimo; Modesti, Michele; Bagno, Andrea; Romanato, Filippo; Grumati, Paolo; Fabozzo, Assunta; Gerosa, Gino.
Afiliação
  • Palmosi T; Laboratory of Cardiovascular Medicine, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padua, Italy.
  • Tolomeo AM; L.i.f.e.L.a.b. Program, Consorzio per la Ricerca Sanitaria (CORIS), Veneto Region Padua, Italy.
  • Cirillo C; Laboratory of Cardiovascular Medicine, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padua, Italy.
  • Sandrin D; L.i.f.e.L.a.b. Program, Consorzio per la Ricerca Sanitaria (CORIS), Veneto Region Padua, Italy.
  • Sciro M; Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Italy.
  • Negrisolo S; L.i.f.e.L.a.b. Program, Consorzio per la Ricerca Sanitaria (CORIS), Veneto Region Padua, Italy.
  • Todesco M; Optics and Bioimaging Lab, Department of Physics and Astronomy, Fondazione Istituto di Ricerca Pediatrica Città della Speranza, University of Padova, Padua, Italy.
  • Caicci F; Azienda Ospedale Padova, Padua, Italy.
  • Santoro M; Laboratory of Immunopathology and Molecular Biology of the Kidney, Department of Women's and Children's Health, University of Padova, Padua, Italy.
  • Dal Lago E; L.i.f.e.L.a.b. Program, Consorzio per la Ricerca Sanitaria (CORIS), Veneto Region Padua, Italy.
  • Marchesan M; Department of Industrial Engineering, University of Padova, Padua, Italy.
  • Modesti M; Department of Biology, University of Padova, Padua, Italy.
  • Bagno A; Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Italy.
  • Romanato F; Department of Industrial Engineering, University of Padova, Padua, Italy.
  • Grumati P; Consultant of Animal and Food Welfare, Padua, Italy.
  • Fabozzo A; Department of Industrial Engineering, University of Padova, Padua, Italy.
  • Gerosa G; L.i.f.e.L.a.b. Program, Consorzio per la Ricerca Sanitaria (CORIS), Veneto Region Padua, Italy.
Front Bioeng Biotechnol ; 10: 1042434, 2022.
Article em En | MEDLINE | ID: mdl-36578513
ABSTRACT
Structural cardiac lesions are often surgically repaired using prosthetic patches, which can be biological or synthetic. In the current clinical scenario, biological patches derived from the decellularization of a xenogeneic scaffold are gaining more interest as they maintain the natural architecture of the extracellular matrix (ECM) after the removal of the native cells and remnants. Once implanted in the host, these patches can induce tissue regeneration and repair, encouraging angiogenesis, migration, proliferation, and host cell differentiation. Lastly, decellularized xenogeneic patches undergo cell repopulation, thus reducing host immuno-mediated response against the graft and preventing device failure. Porcine small intestinal submucosa (pSIS) showed such properties in alternative clinical scenarios. Specifically, the US FDA approved its use in humans for urogenital procedures such as hernia repair, cystoplasties, ureteral reconstructions, stress incontinence, Peyronie's disease, penile chordee, and even urethral reconstruction for hypospadias and strictures. In addition, it has also been successfully used for skeletal muscle tissue reconstruction in young patients. However, for cardiovascular applications, the results are controversial. In this study, we aimed to validate our decellularization protocol for SIS, which is based on the use of Tergitol 15 S 9, by comparing it to our previous and efficient method (Triton X 100), which is not more available in the market. For both treatments, we evaluated the preservation of the ECM ultrastructure, biomechanical features, biocompatibility, and final bioinductive capabilities. The overall analysis shows that the SIS tissue is macroscopically distinguishable into two regions, one smooth and one wrinkle, equivalent to the ultrastructure and biochemical and proteomic profile. Furthermore, Tergitol 15 S 9 treatment does not modify tissue biomechanics, resulting in comparable to the native one and confirming the superior preservation of the collagen fibers. In summary, the present study showed that the SIS decellularized with Tergitol 15 S 9 guarantees higher performances, compared to the Triton X 100 method, in all the explored fields and for both SIS regions smooth and wrinkle.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2022 Tipo de documento: Article